Reports
Reports
Sale
The key features of the market report comprise strategic initiatives by the leading players including mergers and collaborations and new product launches. The major companies in the market are as follows:
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. has a strong market presence and is actively working towards expanding its product portfolio to address various research needs. It offers a range of cloning kits, enzymes, and reagents, such as TOPO cloning kits, GeneArt Seamless Cloning kits, and Gateway cloning systems.
Takara Bio Inc.
Headquartered in Japan, Takara Bio Inc. develops and distributes life science reagents under the Takara®, Clontech®, and Cellartis® brands. It offers high-quality reagents and kits such as PrimeSTAR high-fidelity DNA polymerases and significantly contributes to the cloning and mutagenesis market growth.
Agilent Technologies, Inc.
California-based Agilent Technologies, Inc. is known for innovative solutions for cloning and mutagenesis. One of its key products includes QuikChange site-directed mutagenesis kits that are reported to expedite and simplify site-directed mutagenesis studies.
TransGen Biotech Co., LTD.
TransGen Biotech Co., LTD is a leading biotechnology company that manufactures over 200 molecular and cellular biology reagents. It holds a major market share by providing cost-effective and high-quality products including mutagenesis kits, cloning vectors, and PCR cloning kits.
Other key players in the market include Merck KGaA, Bio-Rad Laboratories, Inc., Promega Corporation, GenScript, Genes2Me, and New England Biolabs.
Cloning and Mutagenesis Market Size
Cloning and Mutagenesis Market Growth
Cloning and Mutagenesis Market Trends
Cloning and Mutagenesis Market Share
Cloning and Mutagenesis Market Regional Analysis
Cloning and Mutagenesis Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cloning and Mutagenesis Market Overview
3.1 Global Cloning and Mutagenesis Market Historical Value (2017-2023)
3.2 Global Cloning and Mutagenesis Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Cloning and Mutagenesis Market Landscape*
5.1 Global Cloning and Mutagenesis: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Cloning and Mutagenesis: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Technology
6 Global Cloning and Mutagenesis Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Cloning and Mutagenesis Market Segmentation (2017-2032)
7.1 Global Cloning and Mutagenesis Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Cloning Kits
7.1.3 Others
7.2 Global Cloning and Mutagenesis Market (2017-2032) by Technique
7.2.1 Market Overview
7.2.2 Topo PCR Cloning
7.2.3 Blunt End Cloning
7.2.4 Seamless Cloning
7.2.5 Site-Directed Mutagenesis
7.3 Global Cloning and Mutagenesis Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Biotechnology Companies
7.3.3 Academic and Research Institute
7.3.4 Others
7.4 Global Cloning and Mutagenesis Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Cloning and Mutagenesis Market (2017-2032)
8.1 North America Cloning and Mutagenesis Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Cloning Kits
8.1.3 Others
8.2 North America Cloning and Mutagenesis Market (2017-2032) by Technique
8.2.1 Market Overview
8.2.2 Topo PCR Cloning
8.2.3 Blunt End Cloning
8.2.4 Seamless Cloning
8.2.5 Site-Directed Mutagenesis
8.3 North America Cloning and Mutagenesis Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Biotechnology Companies
8.3.3 Academic and Research Institute
8.3.4 Others
8.4 North America Cloning and Mutagenesis Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Cloning and Mutagenesis Market (2017-2032)
9.1 Europe Cloning and Mutagenesis Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Cloning Kits
9.1.3 Others
9.2 Europe Cloning and Mutagenesis Market (2017-2032) by Technique
9.2.1 Market Overview
9.2.2 Topo PCR Cloning
9.2.3 Blunt End Cloning
9.2.4 Seamless Cloning
9.2.5 Site-Directed Mutagenesis
9.3 Europe Cloning and Mutagenesis Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Biotechnology Companies
9.3.3 Academic and Research Institute
9.3.4 Others
9.4 Europe Cloning and Mutagenesis Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Cloning and Mutagenesis Market (2017-2032)
10.1 Asia Pacific Cloning and Mutagenesis Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Cloning Kits
10.1.3 Others
10.2 Asia Pacific Cloning and Mutagenesis Market (2017-2032) by Technique
10.2.1 Market Overview
10.2.2 Topo PCR Cloning
10.2.3 Blunt End Cloning
10.2.4 Seamless Cloning
10.2.5 Site-Directed Mutagenesis
10.3 Asia Pacific Cloning and Mutagenesis Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Biotechnology Companies
10.3.3 Academic and Research Institute
10.3.4 Others
10.4 Asia Pacific Cloning and Mutagenesis Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Cloning and Mutagenesis Market (2017-2032)
11.1 Latin America Cloning and Mutagenesis Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Cloning Kits
11.1.3 Others
11.2 Latin America Cloning and Mutagenesis Market (2017-2032) by Technique
11.2.1 Market Overview
11.2.2 Topo PCR Cloning
11.2.3 Blunt End Cloning
11.2.4 Seamless Cloning
11.2.5 Site-Directed Mutagenesis
11.3 Latin America Cloning and Mutagenesis Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Biotechnology Companies
11.3.3 Academic and Research Institute
11.3.4 Others
11.4 Latin America Cloning and Mutagenesis Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Cloning and Mutagenesis Market (2017-2032)
12.1 Middle East and Africa Cloning and Mutagenesis Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Cloning Kits
12.1.3 Others
12.2 Middle East and Africa Cloning and Mutagenesis Market (2017-2032) by Technique
12.2.1 Market Overview
12.2.2 Topo PCR Cloning
12.2.3 Blunt End Cloning
12.2.4 Seamless Cloning
12.2.5 Site-Directed Mutagenesis
12.3 Middle East and Africa Cloning and Mutagenesis Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Biotechnology Companies
12.3.3 Academic and Research Institute
12.3.4 Others
12.4 Middle East and Africa Cloning and Mutagenesis Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Strategic Initiatives
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership and Collaborations
14.3 Analysis by Joint Ventures
14.4 Analysis by Leading Players
14.5 Analysis by Geography
15 Supplier Landscape
15.1 Market Share Analysis, By Region (Top 5 Companies)
15.1.1 Market Share Analysis: Global
15.1.2 Market Share Analysis: North America
15.1.3 Market Share Analysis: Europe
15.1.4 Market Share Analysis: Asia-Pacific
15.1.5 Market Share Analysis: Others
15.2 Thermo Fisher Scientific Inc.
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Takara Bio Inc.
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Agilent Technologies, Inc.
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 TransGen Biotech Co., LTD.
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Merck KGaA
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Bio-Rad Laboratories, Inc.
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Promega Corporation
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 GenScript
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Genes2Me
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
15.11 New England Biolabs
15.11.1 Financial Analysis
15.11.2 Product Portfolio
15.11.3 Demographic Reach and Achievements
15.11.4 Mergers and Acquisitions
15.11.5 Certifications
16 Global Cloning and Mutagenesis Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.